Bristol-Myers Profit Lower, So Are Shares
615856
Bristol-Myers Squibb Co.  on Friday said quarterly profit fell 16 percent on special charges and lower U.S. sales amid competition from rival brands and cheaper generics.
336164
Bristol-Myers Squibb said its third-quarter profit dipped 16 percent from a year ago to 758 million dollars as the pharmaceutical giant boosted research in the face of expiring patents.
106101
U.S. stocks edged lower on Thursday,   dragged down by drug store shares after Wal-Mart Stores Inc.   WMT.N announced it was slashing prices of generic drugs in   Florida.
187282
DuPont Co. , the No. 2 U.S. chemical maker, on Tuesday posted a lower quarterly profit after a large tax gain a year earlier and forecast earnings growth in 2005.
105442
Eli Lilly and Co.  on Thursday forecast profit gains next year below its expected 2006 growth and offered few big surprises at a meeting to describe its experimental drugs, sending shares lower.
89750
Merck and Co. Inc. MRK.N on Tuesday  said fourth-quarter earnings fell 21 percent, hurt by the  withdrawal last September of its blockbuster arthritis drug  Vioxx and related charges.
628463
Eli Lilly and Co.  forecast profit gains next year below its expected 2006 growth of 8 percent to 12 percent, held back by higher costs.
444033
BASEL, Switzerland  - Swiss drugmaker Novartis AG missed forecasts with a 42 percent drop in fourth-quarter net profit, hit by generic competition and a one-off restructuring charge, sending its shares lower.
269107
Pharmaceutical wholesaler McKesson  Corp  reported on Thursday that its quarterly profit  fell 17 percent as results were hit by charges and lower profit  margins on generic drugs.
155227
WellPoint Inc. WLP.N and Humana Inc.  HUM.N on Monday posted lower quarterly profit as the health  insurers grappled with soaring medical costs, sending their  shares down.
593019
Bristol-Myers Squibb Co., which has lost US patent protection on eight of its drugs since 2000, said third-quarter earnings fell 16 percent as costs rose and sales of the Pravachol cholesterol treatment fell.
617822
The drug maker Sanofi-Aventis said its fourth-quarter profit fell 4.6 percent under pressure from European health care reforms and generic competition for its blockbuster medicines. It said earnings would be flat this year. The company, which is based in Paris, declined to comment on reports that it had discussed a merger with Bristol-Myers Squibb. Net profit at Sanofi-Aventis fell to 1.38 billion euros ($1.79 billion) in the fourth quarter from 1.44 billion euros a year earlier. Sales increased 5 percent, to 7.36 billion euros ($9.53 billion) from 7.01 billion euros.
77782
Schering-Plough Corp  on Monday reported third-quarter profit and sales that fell short of Wall Street's target, sending shares down more than 10 percent amid concerns about its flagship cholesterol drugs.
244370
U.S. stocks fell on Friday dragged  down by a string of negative reports from drug makers, with  Pfizer Inc. PFE.N, AstraZeneca Plc. AZN.L and Eli Lilly and  Co. LLY.N delivering bad news about key products.
468942
Merck & Co. MRK.N on Thursday said  its quarterly profit fell 28 percent due to last month's recall  of its Vioxx arthritis drug, and the company predicted 2004  earnings will fall as much as 11 percent because of the recall.
650282
The chemical maker reported a quarterly profit that was lower than expected, in part due to weak demand from the housing and auto markets.
423893
The investment firm posts a strong profit report, but shares slid.